Background: The t(11;14)(q13;q32) is a chromosomal abnormality usually
associated with mantle cell (centrocytic) lymphomas, although it has
occasionally been reported in other chronic lymphoproliferative disord
ers such as chronic lymphocytic leukemia, prolymphocytic leukemia, spl
enic lymphoma with villous lymphocytes, and multiple myeloma. This abn
ormality results in the translocation of the bcl-1 oncogene from chrom
osome 11 to the immunoglobulin heavy chain locus on chromosome 14. The
bcl-1 oncogene is a member of the cyclin gene family, and high levels
of cyclin D1 mRNA are consistently found in malignant B cell prolifer
ations with t(11;14). Patients and methods: We examined cyclin D1 prot
ein expression in 33 patients with low grade lymphoproliferative disor
ders and 2 patients with reactive hyperplasias by Western blot analysi
s using a polyclonal antibody. Results: 8/11 mantle cell lymphomas, 0/
11 chronic lymphocytic leukemias, 0/4 hairy cell leukemias, 0/2 Sezary
syndrome, 0/2 monocytoid B-cell lymphomas, 0/3 follicular lymphomas,
and 0/2 reactive hyperplasias had overexpression of cyclin D1. Cytogen
etic analysis was performed in four cases of mantle cell lymphoma; thr
ee of these cases had the t(11;14), one of which was hypotetraploid wi
th two copies of t(11;14). Immunophenotypically, all cases of mantle c
ell lymphoma and chronic lymphocytic leukemia had coexpression of CD5
and CD20. Conclusion: Mantle cell lymphoma may be difficult to discrim
inate from chronic lymphocytic leukemia, a more indolent disease, on m
orphologic and immunophenotypic grounds. Our findings suggest that ana
lysis of cyclin D1 protein expression may be helpful in differentiatin
g mantle cell lymphomas from other low grade lymphoproliferative disor
ders.